In this paper, the resistance and the gene homology of Acinetobacter calcoaceticus-baumannii strains which were isolated clinically from the Fourth and the Third People's Hospital of Wuxi, China was studied. The prevalence and distribution was observed and recorded. The susceptibility testing was performed with agar dilution technique and compared with the genotype was investigated with randomly amplified polymorphic DNA (RAPD) technique. To these strains, the resistant rates of Ampicillin, Piperacillin, Cefazolin, Nitrofurantoin were 100%, those of Imipenem, Meropenem and Cefoperazone/Sulbactam were 27%, 15% and 12%, respectively. The resistant rates of other β-lactams and quinolones were higher than 60%. The resistant rates of aminoglycosides were higher than 75%. The type A and D included 35 strains and 22 strains, respectively. The same genotype separated from the same and the different endemic areas. It is sensitive to Imipenem, Meropenem and Cefoperazone/Sulbactam among the 100 strains of Acinetobacter calcoaceticus -baumannii. Maybe the 2 strains are Acinetobacter calcoaceticus and 98 strains are Acinetobacter baumannii. The type A and D are the major types, which show cross-transmission in two hospitals in Wuxi.
INTRODUCTION
Acinetobacter spp. are glucose-non-fermentative, non-fastidious, strictly aerobic Gram-negative bacilli, usually occurring in diploid formation, or in chains of variable length [1] . Members of the genus Acinetobacter are ubiguitous organisms, which are serious nosocomial pathogens and show increasing resistance to many commonly prescribed antibiotics [2] . The genus Acinetobacter include A. baumannii, A. calcoaceticus, A. haemolyticus, A. junii, A. johnsonii, A. lwoffii according to the recognized genomic species of Bouvet and Grimont (1986) [3] . However, it is difficult to differentiate between A. baumannii and A. calcoaceticus by the VITEK 32 system. So the strains are named as Acinetobacter calcoaceticus-baumannii or Acinetobacter baumanniicalcoaceticus in the clinical laboratory in China. A. baumanii, A. calcoaceticus, and the unnamed genospecies three and 13 TU are difficult to distinguish phenotypically and are often given the name A. baumanii-A. calcoaceticus complex [4] . P. G. Higgins also reports the species that form the A. calcoaceticus-A. baumannii complex have been grouped together because they are genetically closely related and phenotypically very difficult to differentiate from each other [5] .
The aim of this study was to assess the current levels of antimicrobial susceptibility and the gene homology among clinical isolation of Acinetobacter calcoaceticus -baumanni collected from two hospitals in Wuxi. The outline of this paper was as follows. Section 2 introduces the materials and methods of tests. Section 3 presents results and discussion are presented in Section 4. Conclusions are given in Section 5.
MATERIALS AND METHODS

Bacterial Isolates
We collected and isolated the 100 strains of Acinetobacter calcoaceticusbaumannii between January 2007 and October 2008. Each strain was obtained from a different patient. Bacterial identification was performed using the VITEK 32 system (BioMerieux, France).
Antimicrobial-Susceptibility Testing
The susceptibilities of the 100 strains of Acinetobacter calcoaceticusbaumannii isolates to 27 kinds of antibacterials were determined by the agar dilution technique in Mueller-Hinton (M-H) agar medium with an inoculum of 10 4 CFU per spot, according to National Committee for Clinical Laboratory Standards (NCCLS). Some antibacterials unpublished by NCCLS was operated 
(5) PCR product detection: The mixture of 5 µl amplification products and 1 µl 0.25% bromphenol blue were run on 1% agarose gels with 1 × TAE buffer at 80 V for 40 min. The bands was visualized and photographed with UV Gel Analyzer.
RESULTS
Source of Bacteria
The 55 strains of Acinetobacter calcoaceticus-baumannii from The Fourth People's Hospital of Wuxi and the 45 strains from The Third People's Hospital of Wuxi were investigated. The isolates were obtained from sputum (76), wound secretion (11), medistream urine (5), throat swab (2), bile (2), blood (1), pleural fluid (1) and unknowns (2) . 32% of Acinetobacter calcoaceticus-baumannii separated from the patients who were treated in the intensive care unit (ICU) in Table 2 . The next was Neurosurgery (16%). The pathogens separated from the elder was common (83%), the young at 15% and the child at 2%. 
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Antimicrobial-Susceptibility Testing
All Acinetobacter calcoaceticus-baumannii isolates were multidrug-resistant (MDR) and resistant to more than four antimicrobials. The resistant rate was especially high for Ampicillin (100%), Piperacillin (100%), Cefazolin (100%), Nitrofurantoin (100%), Cefminox (98%), Cefpiramide (98%) and Aztreonam (97%). Imipenem, Meropenem and Cefoperazone/Sulbactam had relatively high susceptibility rates, at 27%, 15% and 12%, respectively. However, the resistant rates of other β-lactams and quinolones were higher than 60% and aminoglycosides were higher than 75%. The antimicrobial -susceptibility testing results were presented in Table 3 . 
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DISCUSSION
Acinetobacter spp. are nonfermentative Gram-negative bacilli that can be isolated from soil, water and other environmental sources, and form part of the normal human skin microflora [4] . In recent year, Acinetobacter spp. increasingly cause nosocomial infections, such as pneumonia, bloodstream infections, and meningitis and urinary tract infections [7] . In our study, the main sites of infection are the respiratory tracts (sputum 76%), wound (wound secretion 11%) and the urinary tract (medistream urine 5%). Most Acinetobacter calcoaceticus-baumannii separated from intensive care unit(ICU)and the elder. Acinetobacter spp. have become resistant to almost all antimicrobial agents that are currently available, including the aminoglycosides, quinolones and broad-spectrum β-lactams. Most strains are resistant to cephalosporins, while resistance to carbapenems is being reported increasingly [8, 9] . Acinetobacter infections have become increasingly difficult to treat because of the emergence of strains resistant to all drugs or all but 1 commonly prescribed antimicrobial drug [10] . The A. baumannii-A. calcoaceticus complex was shown to be more desiccation resistant than A. lwoffii, A.haemolyticus or A.junii [6] . In our study, the Acinetobacter calcoaceticus-baumannii which spread in two hospitals in Wuxi was generally MDR. The resistant rate of the 100 Acinetobacter calcoaceticus -baumannii isolates was especially high. All of the strains were resistant to more than four antibacterials, 15 (15%) were resistant to 26 kinds of antibacterials and 1 (1%) was resistant to 27 kinds. Only Imipenem, Meropenem and Cefoperazone/Sulbactam were sensible to 27 kinds of antibacterials. The antibiotic combinations with sulbactam were suggested as alternative agents for the treatment of MDR Acinetobacter infections. Also, in our study, sulbactam combination Cefoperazone showed a better in vitro activity against Acinetobacter strains than most other antibiotics tested. There are considerable epidemiological and clinically relevant differences among these species. A. calcoaceticus is an environmental organism that, to our knowledge, has never been involved in serious human disease [5] . And important differences in antimicrobial susceptibility exist between A. baumannii and other species in the genus, with A. baumannii being the most resistant species [1] . In our study, only 2 strains are resistant to Ampicillin, Piperacillin, Cefazolin, Nitrofurantoin. So we could conclude that it was possible of the 2 strains that they weren't A. baumannii.
Many different methods have been applied in attempts to identify genotype of Acinetobacter, including plasmid profile, randomly amplified polymorphic DNA (RAPD), repetitive extragenic palindromic sequence-based polymerase chain reaction (REP-PCR), infrequent -restriction-site polymerase chain reaction (IRS-PCR), pulsed-field-gel -electrophoresis (PFGE) and so on. The most accurate approach for the identification was not available in many routine diagnostic laboratories, except in a few specialised reference laboratories. So in our study, as a commonly laboratory, we choose simplified RAPD technique which the extraction of genomic DNA and the PCR reaction mixtures were from kit. The technique is rapid and easy to operate. The 98 strains isolates Acinetobacter calcoaceticus-baumannii of RAPD fingerprint were established with the primer (5'-AAGAGCCCGT-3') of A. baumannii. However, The 2 strains of RAPD fingerprint weren't obtained which maybe were A. calcoaceticus also according to antimicrobial spectrum (2 strains were resistant to Ampicillin, Piperacillin, Cefazolin, Nitrofurantoin among 27 kinds of antibacterials). In the hospital setting, A. baumannii is the most frequently isolated Acinetobacter species [11] . Recent surveillance studies have shown that the isolates of A. baumannii complex are increasingly resistant to cephalosporins, aminoglycosides, fluoroquinolones and carbapenems [12] . So maybe the 98 strains were A. baumannii.
We could know that bands of RAPD fingerprint concentrat between 250 bp and 2000 bp in Fig. 1 and the homology is high which the main band of 10 kinds of genotypes situate between 1000 bp and 2000 bp. In our study, there were the same genotype in the same and the different endemic areas. Most isolates were genetically related, indicating cross-transmission or a point source [13] . Crosstransmission as a major source of infections was demonstrated by the detection of 2 major genotypes in our study. We could conclude that nosocomial transmission results either from contact with environmental sources or from patient-to-patient spread via personnel. Lack of infection control measures may therefore be another explanation for the high incidence of Acinetobacter
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The Resistance and the Gene Homology to Clinical Isolates of Acinetobacter Calcoaceticus-Baumannii calcoaceticus-baumannii infections in two hospitals. So in order to control the Acinetobacter calcoaceticus -baumannii infection we should take basic infection control measures such as disinfection in the endemic areas, hand hygiene and isolation.
CONCLUSION
In our study, the main sites of infection are the respiratory tracts and wound. Most of Acinetobacter calcoaceticus-baumannii separated from intensive care unit (ICU) and the elder. The emergence of MDR Acinetobacter calcoaceticus-baumannii presents a very serious problem for the control of clinical infections. The clinical doctor should properly choose antibacterials according to the susceptibility testing and the condition of patients.
Increased hospitalization associated with MDR Acinetobacter calcoaceticus -baumannii infection emphasizes the need for infection control strategies to prevent cross-transmission in healthcare settings.
